Naomi Kawashima, MD, PhD^1*, Yasuo Kubota, MD, PhD^1*, Carmelo Gurnari, MD^1,2, Carlos Bravo-Perez, MD, PhD^1,3*, Luca Guarnera, MD^1*, Nakisha D Williams, MBBS^1*, Arda Durmaz^1*, Megan Reynold^1*, Arooj Ahmed, MD^1*, Jaroslaw P. Maciejewski, M.D., Ph.D., FACP¹ and Valeria Visconte, PhD¹

¹Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
³Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, University of Murcia, IMIB-Pascual Parrilla, CIBERER - Instituto de Salud Carlos III, Murcia, Spain

Naoki Miyashita, MD^1*, Masahiro Onozawa, M.D., Ph.D.¹, Jun Nagai, M.D.^1*, Shota Yoshida, M.D.^1*, Hiroyuki Kimura, MD^1*, Toshihiro Matsukawa, M.D., Ph.D.^1*, Shinsuke Hirabayashi, M.D., Ph.D.^2*, Akio Mori, M.D., Ph.D.³, Takeshi Kondo, MD, PhD³, Daisuke Hidaka, M.D., Ph.D.^4*, Koichiro Minauchi, M.D., Ph.D.^5*, Akio Shigematsu, M.D., Ph.D.⁶, Junichi Hashiguchi, M.D.^7*, Tetsuyuki Igarashi, M.D.^8*, Yasutaka Kakinoki, M.D., Ph.D.^9*, Yutaka Tsutsumi, M.D., Ph.D.^10*, Hiroshi Iwasaki, M.D.^11*, Shota Yokoyama^12*, Kentaro Wakasa, M.D., Ph.D.^12*, Katsuya Fujimoto, M.D., Ph.D.^13*, Toshimichi Ishihara, M.D.^14*, Hajime Sakai, M.D., Ph.D.¹⁵, Satoshi Iyama, M.D., Ph.D.^16*, Tatsuo Oyake, M.D., Ph.D.^17* and Takanori Teshima, M.D., Ph.D.¹

¹Department of Hematology, Hokkaido University Faculty of Medicine, Sapporo, Japan
²Department of Pediatrics, Faculty of Medicine, Graduate School of Medicine, Hokkaido University, Sapporo, Japan
³Blood Disorders Center, Aiiku Hospital, Sapporo, Japan
⁴Department of Hematology, Sapporo Hokuyu Hospital, Sapporo, Japan
⁵Department of Hematology, Sapporo City General Hospital, Sapporo, Japan
⁶Department of Hematology, Kushiro Rosai Hospital, Kushiro, Japan
⁷Department of Internal Medicine, Kitami Red Cross Hospital, Kitami, Japan
⁸Department of Hematology, Tenshi Hospital, Sapporo, Japan
⁹Department of Hematology, Asahikawa City Hospital, Asahikawa, Japan
¹⁰Hakodate Municipal Hospital, Hakodate, Japan
¹¹Sapporokousei General Hospital, Sapporo, Japan
¹²Department of Hematology, Obihiro Kosei Hospital, Obihiro, Japan
¹³Department of Hematology, National Hospital Organization Hokkaido Cancer Center, Sapporo, Japan
¹⁴Department of Hematology, Kin-ikyo Chuo Hospital, Sapporo, Japan
¹⁵Teine Keijinkai Hospital, Sapporo, Japan
¹⁶Department of Hematology, Sapporo Medical University School of Medicine, Sapporo, Japan
¹⁷Department of Hematology, Internal Medicine Iwate Medical University, Yahaba, Japan

Audrey Da Rocha^1*, Bruno Cassinat, PhD, PharmD², Mael Heiblig^3*, Christian Recher, MD, PhD^4*, Sarah Bertoli^4*, Caroline Bonmati, MD^5*, Gabrielle Roth-Guepin, MD^5*, Anne Zilliox, MD^6*, Marie Laloi^7*, Mathilde Hunault, MD, PhD^7*, Céline Berthon, MD^8*, Nicolas Duployez, MD^9*, Christophe Willekens, MD^10*, Maria Pilar Gallego Hernanz, MD^11*, Marlene Ochmann, MD^12*, Thomas Cluzeau, MD, PhD¹³, Fatiha Chermat^14*, Alexis Caulier, MD, PhD^1*, Emmanuel Raffoux, M.D.^15*, Pierre Fenaux, MD, PhD¹⁵, Jean Pierre Marolleau, MD, PhD¹⁶, Lionel Ades, MD, PhD¹⁷ and Delphine Lebon^1*

¹Hematology Department, CHU Amiens, Amiens, France
²Saint Louis Hospital, APHP, Paris, France
³Hematology Department, Centre Hospitalier Lyon Sud, Pierre-Bénite, France
⁴Hematology Department, IUCT-ONCOPOLE, Toulouse, France
⁵Hematology Department, CHU Nancy, Nancy, France
⁶Hematology Department, ICANS Strasbourg, Strasbourg, France
⁷Hematology Department, CHU Angers, Angers, France
⁸Hematology Department, CHRU Lille, Lille, France
⁹Hematology Laboratory, CHRU Lille, Lille, France
¹⁰Hematology Department, Institut Gustave Roussy, Villejuif, France
¹¹Hematology Department, CHU de Poitiers, Poitiers, France
¹²Hematology Department, CHU Orléans, Orléans, France
¹³CHU Nice, Nice, France
¹⁴Groupe Francophone des Myelodysplasies, Paris, France
¹⁵Hôpital Saint-Louis, Hematology Department, AP-HP, Paris, France
¹⁶Service d’Hématologie Clinique, Centre Hospitalier Universitaire Amiens-Picardie, Amiens, France
¹⁷Hôpital Saint-Louis, Hematology Department, Hopital Saint Louis, Paris, France

Yu-Hung Wang, MD, MSc^1,2*, Adrian Mosquera Orgueira, MD, PhD^3*, Chien-Chin Lin, MD, PhD^2,4*, Chi-Yuan Yao, MD^2*, Min Yen Lo, MD^2*, Cheng-Hong Tsai, MD^2*, Hsin-An Hou, MD, PhD², Wen-Chien Chou, MD, PhD^2,4 and Hwei-Fang Tien, MD, PhD^2,5

¹The University of Manchester, Manchester, United Kingdom
²Division of Hematology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan
³University Hospital of Santiago de Compostela, Department of Hematology, IDIS, SANTIAGO DE COMPOSTELA, Spain
⁴Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan
⁵Department of Internal Medicine, Far-Eastern Memorial Hospital, New Taipei, Taiwan

Camille Gondran^1*, Pierre-Yves Dumas, MD, PhD^2*, Audrey Bidet, MD^3*, Emilie Bérard, MD^4*, Suzanne Tavitian, MD^1*, Thibaut Leguay, MD^5*, Françoise Huguet, M.D.^1*, Isabelle Luquet, MD^6*, Émilie Klein, MD^7*, Audrey Sarry^8*, Anne-Charlotte De Grande^9*, Eric Delabesse, MD, PhD^10*, Édouard Forcade^11*, Cécile Borel, MD^12*, Arnaud Pigneux, MD, PhD^13*, Christian Recher, MD, PhD^14*, Laetitia Largeaud, PharmD, PhD^15* and Sarah Bertoli^16*

¹Centre Hospitalo-Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Service d’Hématologie, Toulouse, France
²Hôpital Haut-Lévèque, Hematology Department, CHU Bordeaux, Pessac, France
³Laboratoire d’Hématologie Biologique, CHU Bordeaux, Bordeaux, France
⁴Department of Epidemiology, Health Economics and Public Health, UMR 1295 CERPOP, University of Toulouse, INSERM, UPS, Toulouse University Hospital (CHU), Toulouse, France
⁵Hematology, CHU Bordeaux, Hôpital du Haut-Lévêque, Pessac, France
⁶Centre Hospitalo-Universitaire de Toulouse, Institut Universitaire du Cancer Toulouse-Oncopole, Laboratoire d'hématologie, Toulouse, France
⁷CHU Bordeaux, Laboratoire d’Hématologie Biologique, Bordeaux, France
⁸Centre Hospitalo-Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Service d'hématologie, Toulouse, France
⁹Centre Hospitalier Universitaire de Bordeaux, Service d’Hématologie Clinique et de Thérapie Cellulaire, Bordeaux, France
¹⁰University Hospital of Toulouse, University of Toulouse 3, Center of Research On, Toulouse, NA, FRA
¹¹Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, F-33000, Bordeaux, France
¹²Hematology department, IUCT Oncopole, Toulouse, France
¹³Hématologie Clinique et Thérapie cellulaire, CHU Bordeaux, Bordeaux, France
¹⁴Hematology Department, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
¹⁵Centre Hospitalo-Universitaire de Toulouse, Institut Universitaire du Cancer Toulouse-Oncopole, Laboratoire d'hématologie, Toulouse, France 7. Centre de Recherches en Cancérologie de Toulouse, Université Toulouse 3 Paul Sabatier, Toulouse, France
¹⁶Service d'Hématologie, Centre Hospitalo-universitaire de Toulouse, Centre de Recherches en Cancérologie de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Université de Toulouse, UPS, INSERM, CNRS, Toulouse, France, Toulouse, France

Thuy Ho, M.D.^1*, Juhi Gor, M.D.^1*, Graeme Murray, M.D., Ph.D.^1*, Ian Bouligny, MD² and Keri Maher, DO¹

¹Massey Cancer Center, Virginia Commonwealth University, Richmond, VA
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Agnese Mattei^1*, Giovanni Marconi, MD², Sonia Ronconi, MD^3*, Delia Cangini^1*, Michela Ceccolini^1*, Claudio Cerchione, MD, PhD⁴, Irene Zacheo^1*, Maria Benedetta Giannini^1*, Marianna Norata^1*, Giovanni Martinelli, MD⁵, Anna Ferrari^1*, Maria Teresa Bochicchio^6*, Martina Ghetti, MSc^6*, Matteo Marchesini^1*, Giorgia Simonetti, PhD^6*, Gerardo Musuraca, MD, PhD^7* and Davide Nappi^1*

¹Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori", Meldola, Italy
²IRCCS Istituto Romagnolo per lo Studio dei Tumori “Dino Amadori” - IRST S.r.l, Meldola, Italy
³IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", Meldola, Italy
⁴Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola (FC), Italy
⁵IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"- IRST S.r.l., Meldola, Italy
⁶IRCSS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST S.r.l, Meldola, Italy
⁷Hematology Unit, Istituto Scientifico Romagnoli per lo Studio e la Cura dei Tumori-IRST, Meldola, Italy

Erin Jay Feliciano, MD^1*, Tara Cronin^1*, Pamela Jeannette Sung, MD, PhD¹, Steven Green, MD^2*, Elizabeth A. Griffiths, MD¹, James E Thompson, MD¹ and Eunice S Wang, MD³

¹Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
²Roswell Park Comprehensive Cancer Center, Buffalo, NY
³Department of Medicine, Roswell Park Comprehensive Cancer Center, BUFFALO, NY

Georgina Gener-Ricos^1*, Jan Philipp Bewersdorf, MD², Sanam Loghavi, MD³, Aaron D. Goldberg, MD, PhD², Christopher Famulare, MS^2*, Ghayas C. Issa⁴, Gautam Borthakur, MD¹, Tapan M. Kadia, MD¹, Bing Z. Carter, PhD⁵, Keyur P. Patel, MBBS, PhD⁶, Michael Andreeff, MD PhD¹, Eytan M. Stein⁷ and Courtney D. DiNardo, MD, MSc¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Memorial Sloan Kettering Cancer Center, New York, NY
³Hematopathology, MD Anderson Cancer Center, Houston, TX
⁴The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
⁶Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY

Shai Shimony, MD^1,2*, Jan Philipp Bewersdorf, MD³, Rory M. Shallis, MD⁴, Yiwen Liu, MS^5*, Eva Johanna Schaefer, MD^6,7*, Amer M. Zeidan, MBBS, MHS⁸, Aaron D. Goldberg, MD, PhD⁹, Eytan M. Stein³, Guido Marcucci, MD¹⁰, Evan C. Chen, MD⁶, Jorge Ramos, MD^11*, R. Coleman Lindsley¹², Anthony Selwyn Stein, MD¹³, Daniel J. DeAngelo¹⁴, Donna S. Neuberg, ScD⁵, Richard M Stone, MD¹⁴, Brian J. Ball, MD¹¹ and Maximilian Stahl, MD¹⁵

¹Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
²Department of Hematology, Rabin Medical Center, Tel Aviv Faculty of Medicine, Tel Aviv, Israel
³Memorial Sloan Kettering Cancer Center, New York, NY
⁴Section of Hematology, Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT
⁵Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
⁶Medical Oncology, Dana Farber Cancer Institute, Boston, MA
⁷Medical Oncology, National Center for Tumor Disease, Heidelberg, Germany
⁸Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT
⁹Memorial Sloan Kettering Cancer Center, New York City, NY
¹⁰Department of Hematologic Malignancies Translational Science, Gehr Family Center for Leukemia Research, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA
¹¹City of Hope Cancer Center, Duarte, CA
¹²Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA
¹³City of Hope National Medical Center, Duarte, CA
¹⁴Dana-Farber Cancer Institute, Boston, MA
¹⁵Dana Farber Institute, Boston, MA

Thura Win Htut, MBBS, MRCP, FRCPath^1*, Myat Min Han, MD^2*, Ei Moe Phyu, MD^3* and Kyaw Zin Thein, MD⁴

¹Department of Haematology, Aberdeen Royal Infimary, Aberdeen, United Kingdom
²Division of Internal Medicine, Interfaith Medical Center, New York
³Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Division of hematology and medical oncology, Comprehensive Cancer Centers of Nevada, Central Valley, Las Vegas, NV

Alex Bataller, MD, PhD^1*, Hagop M. Kantarjian, MD², Tapan M. Kadia, MD¹, Naval Daver, MD¹, Courtney D. DiNardo, MD, MSc¹, Gautam Borthakur, MD¹, Nicholas J. Short, MD¹, Musa Yilmaz, MD^3*, Ghayas C. Issa⁴, Yesid Alvarado Valero, MD¹, Guillermo Montalban-Bravo, MD¹, Abhishek Maiti, MD⁵, Hussein A Abbas, MD, PhD¹, Elias Jabbour⁶, William G. Wierda, MD, PhD⁷, Guillermo Garcia-Manero, MD¹ and Farhad Ravandi, MD, MBBS¹

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³UT MD Anderson Cancer Center, Houston, TX
⁴The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Leukemia, MD Anderson Cancer Center, Houston, TX
⁶University of Texas M.D. Anderson Cancer Ctr., Houston, TX
⁷Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX

Xiaolu Zhu, MD^1*, Feifei Tang^2*, Wenjing Yu, MD^3*, Xiaosu Zhao^4*, Yazhen Qin, M.D.^1*, Qian Jiang, MD⁵, Xiao Jun Huang, MD³ and Hao Jiang^4*

¹Peking University Institute of Hematology, Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
²Peking University Institute of Hematology, Peking University People’s Hospital, Beijing, China
³Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China
⁴Peking University People’s Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China
⁵Peking University People’s Hospital,Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing, China

Shouriyo Ghosh, MD, MBBS, DM¹, Florian Kuchenbauer, MD, PhD, FRCPC^1,2, Ryan J Stubbins, MD, MSc, FRCPC³, Shanee Chung, FRACP, FRCPA, FRCPC¹, Sujaatha Narayanan, MBBS, MRCP, MRCPath^3*, Thomas J. Nevill, MD, FRCPC³, Kevin Song, MD, FRCPC³, Judith Anula Rodrigo, MD, FRCPC^3*, Jennifer White, MD, MSc, FRCPC^3*, Claudie Roy, MD, FRCPC^1*, Yasser Abou Mourad, MD, FRCPC, FACP¹, Stephen H. Nantel, MD, FRCPC³, Donna L. Forrest, MD, FRCPC³, Cynthia L. Toze, MD, MSc, FRCPC³, Kevin A Hay, MD, MSc, FRCPC^1,2, Maryse Power, MD, FRCPath¹ and David Sanford, MD, FRCPC⁴

¹Leukemia/Bone Marrow Transplant Program of British Columbia, University of British Columbia, Vancouver, BC, Canada
²BC Cancer Research Centre, Vancouver, BC, Canada
³University of British Columbia, Vancouver, Canada
⁴Leukemia/Bone Marrow Transplant Program of BC, British Columbia Cancer Agency, University of British Columbia, Vancouver, BC, Vancouver, Canada

Corrado Zuanelli Brambilla, MD^1*, Camilla Baldoni, MS^1*, Adele Santoni, MD^1,2*, Beatrice Esposito Vangone, MD^1,2*, Martina Simoncelli, MD^1,2*, Valentina Venanzi, MD^1,2*, Margherita Malchiodi, MD^1,2*, Elisabetta Abruzzese, MD³ and Monica Bocchia, MD^1,2*

¹UOC Ematologia, Azienda ospedaliero-universitaria Senese, Siena, Italy
²Università di Siena, Siena, Italy
³Hematology Unit, S. Eugenio Hospital, Roma, Italy

Alexandra E. Rojek, MD¹, Benjamin J. McCormick, MD^2*, Joanna Cwykiel, MD^3*, Oluwatobi Odetola, MD³, Yasmin Abaza, MD³, Rohan Achar, MD, MS^4*, Rory M. Shallis, MD⁴, Danielle Bradshaw, MD^5*, Meaghan Standridge, MD^6*, Vamsi K. Kota, MD⁷, Talha Badar, MD² and Anand Ashwin Patel, MD¹

¹Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
²Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL
³Division of Hematology and Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
⁴Section of Hematology, Department of Internal Medicine, Yale School of Medicine, Yale University, New Haven, CT
⁵Georgia Cancer Center, Augusta University Medical Center, Augusta, GA
⁶Department of Medicine, Augusta University, Augusta, GA
⁷Georgia Cancer Center, Augusta University, Augusta, GA

Ziyue Zhou^1*, Yile Zhou^2*, Caihong Sun^1*, Yiyi Yao^1*, Liping Mao, MD^3*, Yi Zhang^1*, Qing Hong^1*, Nanfang Zhuo^1*, Peifeng Pan^1*, Hongyan Tong, PhD^1*, Jie Jin¹ and Huafeng Wang^4*

¹Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
²Zhejiang Provincial Clinical Research Center for Hematological disorders, Hangzhou, China;, Hangzhou, China
³Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, PR China;, Hangzhou, China
⁴The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China

Amyah C. Harris^1*, Christopher S. Bell^1*, Gabriela S. Hobbs, MD², Hanno Hock, MD, PhD², Philip C. Amrein, MD², Rupa Narayan, MD², Amir T. Fathi, MD¹ and Andrew M. Brunner, MD³

¹Massachusetts General Hospital, Boston, MA
²Division of Hematology/Oncology, Massachusetts General Hospital, Boston, MA
³Division of Hematology/Oncology, Dana-Farber Cancer Institute, Boston, MA

Jacob Fuqua, MD¹, Abdulrahman Abonofal, MD² and Salah Ud Din Safi, MBBS, MD^1*

¹West Virginia University, Morgantown, WV
²West Virginia University, Morgantown

Ian Bouligny, M.D.¹, Graeme Murray, M.D., Ph.D.^2*, Thuy Ho, M.D.^2*, Juhi Gor, M.D.^2*, Kyle Zacholski, Pharm.D.^3*, Nolan Wages, Ph.D.^4*, Steven Grant, M.D.^2* and Keri Maher, DO⁵

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Massey Cancer Center, Virginia Commonwealth University, Richmond, VA
³Massey Cancer Center, Department of Pharmacy, Virginia Commonwealth University, Richmond, VA
⁴Massey Cancer Center, Department of Biostatistics, Virginia Commonwealth University, Richmond, VA
⁵Massey Cancer Center, Virginia Commonwealth University, Tucson, AZ

Danielle McQuinn, MD¹, Lauren G Banaszak, MD¹, Paloma L Cabral, MD¹, Erica Reinig, MD^2*, Meredith Hyun, MS^3* and Ryan J Mattison, MD¹

¹Department of Medicine Division of Hematology, Medical Oncology and Palliative Care, University of Wisconsin–Madison, Madison, WI
²Department of Pathology, University of Wisconsin–Madison, Madison, WI
³Biostatistics and Medical Informatics, University of Wisconsin–Madison, Madison, WI

Emma C St. Martin, MD¹, Matthew Schwede, MD², Bita Fakhri, MD, MPH³, Jason Gotlib, MD, MS⁴, Michaela Liedtke, MD⁴, William Shomali, MD⁵, Tian Y. Zhang, MD, PhD⁶ and Gabriel N. Mannis²

¹Department of Medicine, Stanford University, Palo Alto, CA
²Division of Hematology, Department of Medicine, Stanford University, Stanford, CA
³Stanford University School of Medicine, Stanford, CA
⁴Department of Medicine, Division of Hematology, Stanford University School of Medicine, Stanford, CA
⁵Division of Hematology, Stanford Cancer Institute/ Stanford University School of Medicine, Stanford, CA
⁶Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, CA

Dhruvkumar Gadhiya, MBBS, MD¹, Vishrant Amin^2*, Danish Ahmed^3*, Cleris Christian^4*, Parjanya Bhatt^4*, Khawaja Muthammir Hassan^5* and Hardik Dineshbhai Desai, MBBS^6*

¹Internal Medicine, St.Luke's University Health- Anderson Campus, Easton, PA
²vishrantamin1995@gmail.com, Valsad, India
³Sir Seewosagur Ramgoolam Medical College, Mauritius, Dagotiere, Mauritius
⁴BJ Medical College, Ahmedabad, India
⁵Institution King Edward Medical University Lahore Pakistan, lahore, Pakistan
⁶Gujarat Adani Institute of Medical Sciences, Affiliated to K.S.K.V University, Bhuj, India, Bhuj, India

Michele S. Redell, MD¹, Todd A. Alonzo, PhD^2*, Robert Gerbing, MS^3*, Jim Wang, MS^4*, Maureen M. O'Brien, MD⁵, Gwen Nichols, MD⁶, Laura Di Laurenzio, PhD^7*, Sarah K Tasian, MD⁸, C. Michel Zwaan, MD^9*, Dirk Reinhardt, MD, PhD^10*, E. Anders Kolb, MD¹¹ and Todd Cooper, DO¹²

¹Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX
²Univ. of Southern California Keck School of Med., Monrovia, CA
³Children's Oncology Group, Arcadia, CA
⁴Children's Oncology Group, Monrovia, CA
⁵Cancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH
⁶The Leukemia & Lymphoma Society, Rye Brook, NY
⁷Leukemia & Lymphoma Society, Rye Brook, NY
⁸Children's Hospital of Philadelphia, Philadelphia, PA
⁹Princess Máxima Center, Utrecht, Netherlands
¹⁰Essen University Hospital, Essen, Germany
¹¹Leukemia & Lymphoma Society, Bronx, NY
¹²Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Children's Hospital, Seattle, WA

Samuel J. Yates, MD, MSc¹, Elizabeth Terman, BS^2*, Michael Zhang, MD^3*, John Cursio, PhD^4*, Lauren Miller, DPT^5*, Afsheen Norani, PA-C^1*, Jamie Matthews, FNP-BC^1*, Megan Huisingh-Scheetz, MD^6*, Mariam T. Nawas, MD^1* and Wendy Stock, MD⁷

¹Department of Hematology and Oncology, University of Chicago Medical Center, Chicago, IL
²University of Chicago Pritzker School of Medicine, Chicago, IL
³Department of Radiology, University of Chicago Medical Center, Chicago, IL
⁴University of Chicago Biological Sciences Division, Chicago, IL
⁵Department of Therapy Services, University of Chicago Medical Center, Chicago, IL
⁶Department of Geriatrics, University of Chicago Medical Center, Chicago, IL
⁷The University of Chicago Medical Center, Chicago, IL

Troy Climans, MD¹, Camilla Zimmermann, MD, PhD, FRCPC^2,3*, Annette E. Hay, MD, FRCPath, FRCPC⁴, Harriet Richardson, PhD^5,6,7*, Pierre Villeneuve, MD, PhD, FRCPC⁸, Lee Mozessohn, MD, FRCPC^3,9, Andre C. Schuh, MD, FRCPC¹⁰, Janique Dyba, MD, FRCPC^4*, Breffni Hannon, MB BCh BAO, BMedSci, MMedSci, MCFP^2*, David Lee, MD, FRCPC^11*, Rena Buckstein, MD, FRCPC¹², Argin Malakian, RN, MN^2*, Kyle Fitzgibbon, MSc^2*, Joel Lefebvre, MPH^5*, Wei Tu, PhD, MSc^5,6,13* and Gary Rodin, MD, FRCPC^2,14*

¹Department of Medicine, Queen's University, Kingston, ON, Canada
²Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
³Department of Medicine, University of Toronto, Toronto, ON, Canada
⁴Division of Hematology, Department of Medicine, Queen's University, Kingston, ON, Canada
⁵Canadian Cancer Trials Group, Kingston, ON, Canada
⁶Department of Public Health Sciences, Queen's University, Kingston, ON, Canada
⁷Cancer Care and Epidemiology Division, Queen's Cancer Research Institute, Queen's University, Kingston, ON, Canada
⁸University of Ottawa, Ottawa, ON, Canada
⁹Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, CAN
¹⁰Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada
¹¹Queen's University, Kingston, ON, CAN
¹²Odette Cancer Centre, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada
¹³Queen's Cancer Research Institute, Queen's University, Kingston, ON, Canada
¹⁴Department of Psychiatry, University of Toronto, Toronto, ON, Canada

Michael Lübbert, MD¹, Claudia Schmoor^2*, Olga Grishina^2*, Christoph Rummelt, MD^2*, Johanna Thomas, M.Sc.^1*, Michael Heuser, MD³, Konstanze Döhner⁴, Hartmut Döhner, MD⁴, Heiko Becker, MD^1* and Ralph Wäsch, MD²

¹Department of Hematology, Oncology and Stem Cell Transplantation, Faculty of Medicine, University of Freiburg, Freiburg, Germany
²University of Freiburg Medical Center, Freiburg, Germany
³Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
⁴Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany

Katarzyna Majstrowicz, PhD^1,2*, Katharina Waack^1*, Evangelia Antoniou, MD^3*, Naghmeh Niktoreh, MD^4*, Gwen Nichols, MD⁵, Laura Di Laurenzio, PhD^6*, Michele S. Redell, MD⁷, Todd Cooper, DO⁸, E. Anders Kolb, MD⁹, Sarah K Tasian, MD¹⁰, Franco Locatelli, MD, PhD¹¹, C. Michel Zwaan, MD^12,13* and Dirk Reinhardt, MD^2,4

¹Pediatric Research Network, Essen, Germany
²AML-BFM Study Group, Essen, Germany
³University Children’s Hospital Essen. Department of Pediatric Hematology and Oncology, Essen, Germany
⁴Department of Pediatrics III, University Children’s Hospital Essen, University of Duisburg-Essen, Essen, Germany
⁵The Leukemia & Lymphoma Society, Rye Brook, NY
⁶Leukemia & Lymphoma Society, Rye Brook, NY
⁷Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX
⁸Division of Pediatric Hematology, Oncology, Bone Marrow Transplant & Cellular Therapy, Seattle Children's Hospital, Seattle, WA
⁹Leukemia & Lymphoma Society, Bronx, NY
¹⁰Children's Hospital of Philadelphia, Philadelphia, PA
¹¹Department of Pediatric Hematology/Oncology, Cell and Gene Therapy, IRCCS Bambino Gesù Children’s Hospital, Catholic University of the Sacred Heart, Rome, Italy
¹²Prinses Máxima Center for Pediatric Oncology Research, Utrecht, Netherlands
¹³Erasmus University Medical Center, Rotterdam, Netherlands